• 1
    Kinosita R. Studies on the cancerogenic chemical substances. Trans. Soc. Pathol. Jpn 1937; 27: 665727.
  • 2
    Farber E. Similarities in the sequence of early histological changes induced in the liver of the rat by ethionine, 2-acetylaminofluorene, and 3-methyl-4-dimethylaminobenzene. Cancer Res. 1956; 16: 1428.
  • 3
    Alison M, Golding M, Lalani N, Sarraf C. Wound healing in the liver with particular reference to stem cells. Philos. Trans. R. Soc. Lond. B Biol. Sci. 1998; 353: 87794.
  • 4
    Sell S. Liver stem cells. Mod. Pathol. 1994; 7: 10512.
  • 5
    Sigal SH, Brill S, Fiorino AS, Reid LM. The liver as a stem cell and lineage system. Am. J. Physiol. 1992; 263: G13948.
  • 6
    Fausto N. Liver stem cells. In: Arias IM, Boyer JL, Fausto N, Jakoby WB, Schachter DA, Shafritz DA, eds. The Liver. New York: Raven, 1994; 150118.
  • 7
    De Vos R, Desmet V. Ultrastructural characteristics of novel epithelial cell types identified in human pathological liver specimens with chronic ductular reaction. Am. J. Pathol. 1992; 140: 144150.
  • 8
    Lee JH, Rim HJ, Sell S. Heterogeneity of the ‘oval cell’ response in the hamster liver during cholangiocarcinogenesis following Clonorchis sinensis infection and dimethylnitrosamine treatment. J. Hepatol. 1997; 26: 131323.
  • 9
    Tee LB, Smith PG, Yeoh GC. Expression of alpha, mu and pi class glutathione S-transferases in oval and ductal cells in liver of rats placed on a choline-deficient, ethionine-supplemented diet. Carcinogenesis 1992; 13: 187985.
  • 10
    Tee L, Kirilak Y, Huang W-H, Smith PGJ, Morgan RH, Yeoh GCT. Dual phenotypic expression of hepatocytes and bile ductular markers in developing and preneoplastic rats. Carcinogenesis 1996; 17: 2519.
  • 11
    Evarts RP, Nagy P, Marsden E, Thorgeirsson SS. A precursor-product relationship exists between oval cells and hepatocytes in rat liver. Carcinogenesis 1987; 8: 173740.
  • 12
    Evarts RP, Nagy P, Nakatsukasa H, Marsden E, Thorgeirsson SS. In vivo differentiation of rat liver oval cells into hepatocytes. Cancer Res. 1989; 49: 15417.
  • 13
    Yasui O, Miura N, Kawarada K, Koyama K, Sugiyama T. Isolation of oval cells from long-evans cinnamon rats and their transformation into hepatocytes in vivo in the rat liver. Hepatology 1997; 25: 32934.
  • 14
    Braun L, Goyette M, Yaswen P, Thompson NL, Fausto N. Growth in culture and tumorigenicity after transfection with the ras oncogene of liver epithelial cells from carcinogen-treated rats. Cancer Res. 1987; 47: 411624.
  • 15
    Lazaro CA, Rhim JA, Yamada Y, Fausto N. Generation of hepatocytes from oval cell precursors in culture. Cancer Res. 1998; 58: 551422.
  • 16
    Tee LB, Kirilak Y, Huang WH, Morgan RH, Yeoh GCT. Differentiation of oval cells into duct-like cells in preneoplastic liver of rats placed on a choline-deficient diet supplemented with ethionine. Carcinogenesis 1994; 15: 274756.
  • 17
    Yavorkovsky L, Lai E, Ilic Z, Sell S. Participation of small intraportal stem cells in the restitutive response of the liver to periportal necrosis induced by allyl alcohol. Hepatology 1995; 21: 170212.
  • 18
    Theise ND, Saxena R, Portmann BC et al. The canals of Hering and hepatic stem cells in humans. Hepatology 1999; 30: 142533.
  • 19
    Paku S, Schnur J, Nagy P, Thorgeirsson SS. Origin and structural evolution of the early proliferating oval cells in rat liver. Am. J. Pathol. 2001; 158: 131323.
  • 20
    Suzuki A, Zheng YW, Kaneko S et al. Clonal identification and characterisation of self-renewing pluripotent stem cells in the developing liver. J. Cell Biol. 2002; 156: 17384.
  • 21
    Suzuki A, Zheng Y, Kondo R et al. Flow-cytometric separation and enrichment of hepatic progenitor cells in the developing mouse liver. Hepatology 2000; 32: 12309.
  • 22
    Matsusaka S, Tsujimura T, Toyosaka A et al. Role of c-kit receptor tyrosine kinase in development of oval cells in the rat 2-acetylaminofluorene/partial hepatectomy model. Hepatology 1999; 29: 6706.
  • 23
    Omori N, Omori M, Evarts RP et al. Partial cloning of rat CD34 cDNA and expression during stem cell-dependent liver regeneration in the adult rat. Hepatology 1997; 26: 7207.
  • 24
    Petersen BE, Goff JP, Greenberger JS, Michalopoulos GK. Hepatic oval cells express the hematopoietic stem cell marker Thy-1 in the rat. Hepatology 1998; 27: 43345.
  • 25
    Crosby HA, Kelly DA, Strain AJ. Human hepatic stem-like cells isolated using c-kit or CD34 can differentiate into biliary epithelium. Gastroenterology 2001; 120: 53444.
  • 26
    Lagasse E, Connors H, Al-Dhalimy M et al. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat. Med. 2000; 6: 122934.
  • 27
    Petersen BE, Bowen WC, Patrene KD et al. Bone marrow as a potential source of hepatic oval cells. Science 1999; 14: 116870.
  • 28
    Theise ND, Badve S, Saxena R et al. Derivation of hepatocytes from bone marrow calls in mice after radiation-induced myeloablation. Hepatology 2000; 31: 23540.
  • 29
    Theise ND, Nimmakayalu M, Gardner R et al. Liver from bone marrow in humans. Hepatology 2000; 32: 1116.
  • 30
    Alison MR, Poulsom R, Jeffery R et al. Hepatocytes from non-hepatic adult stem cells. Nature 2000; 406: 2578.
  • 31
    Sell S. Heterogeneity and plasticity of hepatocyte lineage cells. Hepatology 2001; 33: 73850.
  • 32
    Hsia CC, Evarts RP, Nakatsukasa H, Marsden ER, Thorgeirsson SS. Occurrence of oval-type cells in hepatitis B virus-associated human hepatocarcinogenesis. Hepatology 1992; 16: 132733.
  • 33
    Hsia CC, Thorgeirsson SS, Tabor E. Expression of hepatitis B surface and core antigens and transforming growth factor-alpha in ‘oval cells’ of the liver in patients with hepatocellular carcinoma. J. Med. Virol. 1994; 43: 21621.
  • 34
    Libbrecht L, Desmet V, Van Damme B, Roskams T. Deep intralobular extension of human hepatic ‘progenitor cells’ correlates with parenchymal inflammation in chronic viral hepatitis: can ‘progenitor cells’ migrate? J. Pathol. 2000; 192: 3738.
  • 35
    Gerber MA, Thung SN, Shen S, Stromeyer FW, Ishak KG. Phenotypic characterisation of hepatic proliferation. Antigenic expression of proliferating epithelial cells in fetal liver, massive hepatic necrosis and nodular transformation of the liver. Am. J. Pathol. 1983; 110: 704.
  • 36
    Uchida T, Peters RL. The nature and origin of proliferated bile ductules in alcoholic liver disease. Am. J. Clin. Pathol. 1983; 79: 32633.
  • 37
    Desmet VJ. Intrahepatic bile ducts under the lens. J. Hepatol. 1985; 1: 54559.
  • 38
    Lowes KN, Brennan BA, Yeoh GC, Olynyk JK. Oval cell numbers in human chronic liver diseases are directly related to disease severity. Am. J. Pathol. 1999; 154: 53741.
  • 39
    Ray MB, Medenhall CL, French SW, Gartside PS. Bile duct changes in alcoholic liver disease. Liver 1993; 13: 3645.
  • 40
    Libbrecht L, Desmet V, Van Damme B, Roskams T. The immunohistochemical phenotype of dysplastic foci in human liver: correlation with putative progenitor cells. J. Hepatol. 2000; 33: 7684.
  • 41
    Nagy P, Kiss A, Schnur J, Thorgeirsson SS. Dexamethasone inhibits the proliferation of hepatocytes and oval cells but not bile duct cells in rat liver. Hepatology 1998; 28: 4239.
  • 42
    Knight B, Yeoh GCT, Husk KL et al. Impaired preneoplatic changes and liver tumour formation in tumour necrosis factor receptor type 1 knockout mice. J. Exp. Med. 2000; 192: 180918.
  • 43
    Olynyk JK, Yeoh GC, Ramm GA et al. Gadolinium chloride suppresses hepatic oval cell proliferation in rats with biliary obstruction. Am. J. Pathol. 1998; 152: 34752.
  • 44
    Rosenberg D, Ilic Z, Yin L, Sell S. Proliferation of hepatic lineage cells of normal C57BL and interleukin-6 knockout mice after cocaine-induced periportal injury. Hepatology 2000; 31: 94855.
  • 45
    Rose TM, Bruce AG. Oncostatin M is a member of a cytokine family that includes leukemia-inhibitory factor, granulocyte colony-stimulating factor, and interleukin 6. Proc. Natl Acad. Sci. USA 1991; 88: 86415.
  • 46
    Omori N, Evarts RP, Omori M, Hu Z, Marsden ER, Thorgeirsson SS. Expression of leukemia inhibitory factor and its receptor during liver regeneration in the adult rat. Lab. Invest. 1996; 75: 1524.
  • 47
    Kamiya A, Kinoshita T, Miyajima A. Oncostatin M and hepatocyte growth factor induce hepatic maturation via distinct signaling pathways. FEBS Lett. 2001; 492: 904.
  • 48
    Bisgaard HC, Muller S, Nagy P, Rasmussen LJ, Thorgeirsson SS. Modulation of the gene network connected to IFN-γ in liver regeneration from oval cells. Am. J. Pathol. 1999; 155: 107585.
  • 49
    Popper H, Kent G, Stein R. Ductular cell reaction in the liver in hepatic injury. J. Mt Sinai Hosp. 1957; 24: 5516.
  • 50
    Evarts RP, Hu Z, Fujio K, Marsden ER, Thorgeirsson SS. Activation of the hepatic stem cell compartment in the rat: role of transforming growth factor, hepatocyte growth factor, and acidic fibroblast growth factor in early proliferation. Cell Growth Diff. 1993; 4: 55561.
  • 51
    Braun L, Mikumo R, Fausto N. Production of hepatocellular carcinoma by oval cells: cell cycle expression of c-myc and p53 at different stages of oval cell transformation. Cancer Res. 1989; 49: 155461.
  • 52
    Nagy P, Bisgaard HC, Santoni-Rugiu E, Thorgeirsson SS. In vivo infusion of growth factors enhances the mitogenic response of rat hepatic ductal (oval) cells after administration of 2-acetylaminofluorene. Hepatology 1996; 23: 719.
  • 53
    Imai T, Matsui T, Nakanishi H et al. Expression of hepatocyte growth factor and c-met mRNA's during rat chemically induced hepatocarcinogenesis. Carcinogenesis 1996; 17: 1924.
  • 54
    Hu Z, Evarts RP, Fujio K et al. Expression of transforming growth factor alpha/epidermal growth factor receptor, hepatocyte growth factor/c-met and acidic fibroblast growth factor/fibroblast growth factors during hepatocarcinogenesis. Carcinogenesis 1996; 17: 9318.
  • 55
    Nishizaki T, Takenaka K, Yanaga K et al. Elevation of hepatocyte growth factor levels in portal and hepatic veins immediately after hepatic resection in cirrhotic patients. Am. J. Gastroenterol. 1995; 90: 3312.
  • 56
    Shiota G, Okano J, Kawasaki H, Kawamoto T, Nakamura T. Serum hepatocyte growth factor levels in liver diseases: clinical implications. Hepatology 1995; 21: 10612.
  • 57
    Tomiya T, Tani M, Yamada S, Hayashi S, Umeda N, Fujiwara K. Serum hepatocyte growth factor levels in hepatectomised and nonhepatectomised surgical patients. Gastroenterology 1992; 103: 16214.
  • 58
    Crosby HA, Hubscher SG, Joplin RE, Kelly DA, Strain AJ. Immunolocalisation of OV-6, a putative progenitor cell marker in human fetal and diseased pediatric liver. Hepatology 1998; 28: 9805.
  • 59
    Roskams T, Vos RD, Van Eyken P, Myazaki H, Damme BV, Desmet V. Hepatic OV-6 expression in human liver disease and rat experiments: evidence for hepatic progenitor cells in man. J. Hepatol. 1998; 29: 45563.
  • 60
    Marsden ER, Hu Z, Fujio K, Nakatsukasa H, Thorgeirsson SS, Evarts RP. Expression of acidic fibroblast growth factor in regenerating liver and during hepatic differentiation. Lab. Invest. 1992; 67: 42733.
  • 61
    Evarts RP, Nakatsukasa H, Marsden ER, Hu Z, Thorgeirsson SS. Expression of transforming growth factor-alpha in regenerating liver and during hepatic differentiation. Mol. Carcinog. 1992; 5: 2531.
  • 62
    Park DY, Suh KS. Transforming growth factor-beta1 protein, proliferation and apoptosis of oval cells in acetylaminofluorene-induced rat liver regeneration. J. Korean Med. Sci. 1999; 14: 5318.
  • 63
    Mayer M. Biochemical and biological aspects of the plasminogen activation system. Clin. Biochem. 1990; 23: 197211.
  • 64
    Bisgaard HC, Santoni-Rugui E, Nagy P, Thorgeirsson SS. Modulation of the plasminogen activator/plasmin system in rat liver regenerating by recruitment of oval cells. Lab. Invest. 1998; 78: 23746.
  • 65
    Naldini L, Vigna E, Narsimhan RP et al. Hepatocyte growth factor (HGF) stimulated the tyrosine kinase activity of the receptor encoded for by the proto-oncogene c-MET. Oncogene 1991; 6: 5014.
  • 66
    Kim TH, Mars WM, Stolz DB, Petersen BE, Michalopoulos GK. Extracellular matrix remodelling at the early stages of liver regeneration in the rat. Hepatology 1997; 26: 896904.
  • 67
    Mars WM, Zarnegar R, Michalopoulos GK. Activation of hepatocyte growth factor by the plasminogen activators uPA and tPA. Am. J. Pathol. 1993; 143: 94958.
  • 68
    Miyazawa K, Shimomura T, Naka D, Kitamura N. Proteolytic activation of hepatocyte growth factor in response to tissue injury. J. Biol. Chem. 1994; 269: 896670.
  • 69
    Taipale J, Koli K, Keski-Oja J. Release of transforming growth factor-beta 1 from the pericellular matrix of cultured fibroblasts and fibrosarcoma cells by plasmin and thrombin. J. Biol. Chem. 1992; 267: 25 37884.
  • 70
    Fujio K, Evarts RP, Hu Z, Marsden ER, Thorgeirsson SS. Expression of stem cell factor and its receptor, c-kit, during liver regeneration from putative stem cells in adult rat. Lab. Invest. 1994; 70: 51116.
  • 71
    Lenzi R, Liu MH, Tarsetti F et al. Histogenesis of bile duct-like cells proliferating during ethionine hepatocarcinogenesis. Lab. Invest. 1992; 66: 390402.
  • 72
    Alpini G, Dabeva M, Salvi R, Shafritz DA, Tavoleni N. Distribution of albumin and alpha-fetoprotein mRNAs in normal, hyperplastic and preneoplastic rat liver. Am. J. Pathol. 1992; 141: 62332.
  • 73
    Akhurst B, Croager EJ, Farley-Roche CA et al. A modified choline-deficient, ethionine-supplemented diet protocol effectively induces oval cells in mouse liver. Hepatology 2001; 34: 51922.
  • 74
    Tarsetti F, Lenzi R, Salvi R et al. Liver carcinogenesis associated with feeding of ethionine in a choline-free diet: evidence against a role of oval cells in the emergence of hepatocellular carcinoma. Hepatology 1993; 18: 596603.
  • 75
    Tatematsu M, Kaku T, Medline A, Farber E. Intestinal metaplasia is a common option of oval cells in relation to cholangiofibrosis in liver of rats exposed to 2-acetylaminofluorene. Lab. Invest. 1985; 52: 35462.
  • 76
    Dabeva MD, Shafritz DA. Activation, proliferation and differentiation of progenitor cells into hepatocytes in the d-galactosamine model of liver regeneration. Am. J. Pathol. 1993; 143: 160620.
  • 77
    Lemire JM, Shiojiri N, Fausto N. Oval cell proliferation and the origin of small hepatocytes in liver injury induced by d-galactosamine. Am. J. Pathol. 1991; 139: 53552.
  • 78
    Factor VM, Radaeva SA, Thorgeirsson SS. Origin and fate of oval cells in dipin-induced hepatocarcinogenesis in the mouse. Am. J. Pathol. 1994; 145: 40922.
  • 79
    Haruna Y, Saito K, Spaulding S, Nalesnik MA, Gerber MA. Identification of bipotential progenitor cells in human liver development. Hepatology 1996; 23: 47681.
  • 80
    Engelhardt NV, Factor VM, Medvinsky AL, Baranov VN, Lazareva MN, Poltoranina VS. Common antigen of oval and biliary epithelial cells (A6) is a differentiation marker of epithelial and erythroid cell lineages in early development of the mouse. Differentiation 1993; 55: 1926.